Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	HeFH (Placebo in Parent Study): Evolocumab 420 mg QM	49
Overall Study	STARTED	HeFH (Evolocumab in Parent Study): Evolocumab 420 mg QM	101
Overall Study	STARTED	HoFH: Evolocumab 420 mg QM	13
Overall Study	Received Study Drug	HeFH (Placebo in Parent Study): Evolocumab 420 mg QM	49
Overall Study	Received Study Drug	HeFH (Evolocumab in Parent Study): Evolocumab 420 mg QM	101
Overall Study	Received Study Drug	HoFH: Evolocumab 420 mg QM	12
Overall Study	COMPLETED	HeFH (Placebo in Parent Study): Evolocumab 420 mg QM	48
Overall Study	COMPLETED	HeFH (Evolocumab in Parent Study): Evolocumab 420 mg QM	98
Overall Study	COMPLETED	HoFH: Evolocumab 420 mg QM	11
Overall Study	NOT COMPLETED	HeFH (Placebo in Parent Study): Evolocumab 420 mg QM	1
Overall Study	NOT COMPLETED	HeFH (Evolocumab in Parent Study): Evolocumab 420 mg QM	3
Overall Study	NOT COMPLETED	HoFH: Evolocumab 420 mg QM	2

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02624869/flow